Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Lungs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02475720
What this trial is testing

Survey on the Treatment Reality of Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung Cancer(NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 2,000
Early research (Phase 1)Study completedNCT03846310
What this trial is testing

Evaluate Immunotherapy Combinations in Participants With Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer MetastaticNon Small Cell Lung CancerNonsquamous Nonsmall Cell Neoplasm of Lung+1 more
Arcus Biosciences, Inc. 77
Early research (Phase 1)Looking for participantsNCT07488923
What this trial is testing

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

Who this might be right for
Small Cell Lung Cancer (SCLC )Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)Gastroenteropancreatic NEC (GEP NEC)+1 more
Moonlight Bio, Inc 110
Large-scale testing (Phase 3)UnknownNCT00168896
What this trial is testing

Small Cell Lung Cancer (SCLC) in Extensive Disease Stage

Who this might be right for
Small Cell Lung Cancer
Charite University, Berlin, Germany 286
Testing effectiveness (Phase 2)Study completedNCT02937818
What this trial is testing

A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer

Who this might be right for
Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma
AstraZeneca 72
Testing effectiveness (Phase 2)WithdrawnNCT04267913
What this trial is testing

Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial)

Who this might be right for
Lung Squamous Cell CarcinomaRecurrent Lung CarcinomaStage IV Lung Cancer AJCC v8+2 more
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Study completedNCT02862288
What this trial is testing

Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia.

Who this might be right for
Lung TumorBone TumorRenal Tumor
Centre Hospitalier Universitaire de Besancon 30
Not applicableActive Not RecruitingNCT06146920
What this trial is testing

Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation

Who this might be right for
MelanomaNon-small Cell Lung Cancer
Massachusetts General Hospital 39
Not applicableStudy completedNCT05908799
What this trial is testing

Emulation of the KEYNOTE-189 Trial Using Electronic Health Records

Who this might be right for
Non-small Cell Lung CancerMetastatic Lung Cancer
Aetion, Inc. 1,854
Early research (Phase 1)Looking for participantsNCT06592638
What this trial is testing

Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 30
Testing effectiveness (Phase 2)Ended earlyNCT03709706
What this trial is testing

Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab

Who this might be right for
Neoplasms
GlaxoSmithKline 34
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Early research (Phase 1)Study completedNCT01219348
What this trial is testing

IDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients.

Who this might be right for
NSCLCLung Cancer
Inge Marie Svane 14
Not applicableStudy completedNCT03695835
What this trial is testing

A Data Collection Study for Patients With Adenocarcinoma Treated With the MyVaccx Immunotherapy Regimen.

Who this might be right for
Adenocarcinoma
Gary Onik MD 27
Testing effectiveness (Phase 2)Ended earlyNCT01573338
What this trial is testing

Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer)

Who this might be right for
Small Cell Lung Carcinoma
Bayer 43
Large-scale testing (Phase 3)Study completedNCT00449033
What this trial is testing

A Phase III Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients With Stage IIIb With Effusion and Stage IV Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Bayer 904
Very early researchWithdrawnNCT06284226
What this trial is testing

An Exploratory Clinical Study to Evaluate the Safety and Efficacy of NK Cells (Combined With Standard Therapy) in the Treatment of Solid Tumor Patients

Who this might be right for
Solid Tumors (Pancreatic Cancer, Esophageal Cancer, Gastric Cancer, Cholangiocarcinoma, Lung Cancer and Ovarian Cancer)
Beijing Kejing Biotechnology Co., Ltd.
Early research (Phase 1)UnknownNCT04153799
What this trial is testing

Study of CXCR5 Modified EGFE Chimeric Antigen Receptor Autologous T Cells in EGFR- Positive Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Sun Yat-sen University 11
Not applicableStudy completedNCT04552535
What this trial is testing

A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung

Who this might be right for
Squamous Non-small Cell Lung Cancer
Boehringer Ingelheim 200
Not applicableActive Not RecruitingNCT05183932
What this trial is testing

Surgery Versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerNon-small Cell Lung Cancer
Washington University School of Medicine 446
Next Page